Year-to-date net sales of $139.9 million; up 18.5% year-over-year
Heightened interest in probiotic foods with
bioavailable nutrients drives volume growth of Lifeway Kefir and
Farmer Cheese
20th consecutive quarter of year-over-year
growth
Year-to-date gross profit margin increased to
26.2%
MORTON
GROVE, Ill., Nov. 14,
2024 /PRNewswire/ -- Lifeway Foods, Inc. (Nasdaq:
LWAY) ("Lifeway" or "the Company"), the leading U.S. supplier of
kefir and fermented probiotic products to support the microbiome,
today reported financial results for the third quarter ended
September 30, 2024.
"I'm thrilled to announce our 20th consecutive
quarter of net sales growth, marking an impressive 5 consecutive
years' worth of quarterly growth for Lifeway on the topline,"
commented Julie Smolyansky,
President and Chief Executive Officer of Lifeway Foods. "We
continued this record year by delivering our second largest quarter
ever with $46.1 million in net sales,
up double-digits year-over-year, driven by the continued volume
growth of our flagship drinkable Lifeway Kefir. We also saw growth
in our cheese category, as our strategic sales investments have
capitalized on the increasing consumer interest in soft cheese
products, such as our Lifeway Farmer Cheese. Our effective sales
and marketing investments continue to create demand, drive trial
and accelerate velocities in our core offerings, as evidenced by
our remarkable, volume-led results. Recently, our strawberry banana
flavor of Lifeway Kefir gained placement at select locations of our
largest retail customer, with an estimated total of 1,000 stores
once resets are complete in the fourth quarter. We also anticipate
that our ProBugs will gain incremental distribution at around 260
stores with a regional retailer in December, and our Farmer Cheese
will gain placement with a large national retailer in an estimated
1400 stores by the end of the first quarter of 2025. We will
continue to strategically evaluate opportunities to elevate the
exposure of our core Lifeway offerings. Interest in protein-rich
foods with probiotics and bioavailable nutrients like Lifeway Kefir
and Farmer Cheese is higher than ever, and we believe that, in our
38-year history, our trajectory has never been stronger."
Smolyansky continued, "The strong third quarter performance
extends our track record of execution on our growth plan to
consolidate our market leading position. Compared to the same
period 5 years ago, the year we initiated our Lifeway 2.0 Strategic
Growth Plan, our year-to-date net sales and gross profit have grown
by 98.4% and 115.3%, respectively, which has led to substantial
shareholder value creation. We continued to deprioritize private
label manufacturing during the quarter, focusing on our branded
products to protect Lifeway's category dominance and visibility,
streamline operations and further improve margins. As we continue
to ship higher volumes of our Lifeway branded products, we will
continue to realize manufacturing efficiencies and favorable fixed
cost absorption, driving operating leverage across the business.
The whole Lifeway team has contributed to our strong operational
execution. We are on pace for record-breaking net sales in 2024,
and I believe we are poised to continue this excellent momentum
into the fourth quarter and 2025."
Third Quarter 2024 Results
Net sales were $46.1 million for
the third quarter ended September 30,
2024, an increase of $5.2
million or 12.7% from the same period in 2023. The net sales
increase was primarily driven by higher volumes of our branded
drinkable kefir.
Gross profit as a percentage of net sales was 25.7% for the
third quarter ended September 30,
2024.
Selling, general and administrative expenses as a percentage of
net sales were 16.4% for the third quarter ended September 30, 2024.
The Company reported net income of $3.0
million or $0.20 per basic and
$0.19 per diluted common share for
the third quarter ended September 30,
2024.
Year-to-Date 2024 Results
Net sales were $139.9 million for
the nine months ended September 30,
2024, an increase of $21.9
million or 18.5% from the same period in 2023. The net sales
increase was primarily driven by higher volumes of our branded
drinkable kefir.
Gross profit as a percentage of net sales was 26.2% for the nine
months ended September 30, 2024, an
improvement when compared to the same period in 2023, due to the
higher volumes of our branded products, which provided
manufacturing efficiencies and favorable fixed cost absorption.
Selling, general and administrative expenses as a percentage of
net sales were 16.5% for the nine months ended September 30, 2024.
The Company reported net income of $9.2
million or $0.62 per basic and
$0.60 per diluted common share for
the nine months ended September 30,
2024, compared to net income of $7.4
million or $0.50 per basic and
$0.49 per diluted common share during
the same period in 2023.
Conference Call and Webcast
A webcast with Lifeway's
President and Chief Executive Officer discussing these results with
additional comments and details is available through the "Investor
Relations" section of the Company's website at
https://lifewaykefir.com/webinars-reports/.
About Lifeway Foods, Inc.
Lifeway Foods, Inc., which has been recognized as one of Forbes'
Best Small Companies, is America's leading supplier of the
probiotic, fermented beverage known as kefir. In addition to its
line of drinkable kefir, the company also produces a variety of
cheeses and a ProBugs line for kids. Lifeway's tart and tangy
fermented dairy products are now sold across the United States, Mexico, Ireland, South
Africa, United Arab
Emirates and France. Learn
how Lifeway is good for more than just you at lifewayfoods.com.
Forward-Looking Statements
This press release contains "forward-looking statements" as
defined in the Private Securities Litigation Reform Act of 1995
regarding, among other things, Lifeway's outlook, expected
manufacturing efficiencies and fixed cost absorption, expectations
regarding future operating and financial performance, future
business strategy and objectives and expected shipping to
Dubai and the
United Arab Emirates. These
statements use words, and variations of words, such as "will,"
"continue," "build," "future," "increase," "drive," "believe,"
"look," "ahead," "confident," "deliver," "outlook," "expect," and
"predict." You are cautioned not to rely on these forward-looking
statements. These forward-looking statements are made as of the
date of this press release, are based on current expectations of
future events and thus are inherently subject to a number of risks
and uncertainties, many of which involve factors or circumstances
beyond Lifeway's control. If underlying assumptions prove
inaccurate or known or unknown risks or uncertainties materialize,
actual results could vary materially from Lifeway's expectations
and projections. These risks, uncertainties, and other factors
include: price competition; the decisions of customers or
consumers; the actions of competitors; changes in the pricing of
commodities; the effects of government regulation; possible delays
in the introduction of new products; and customer acceptance of
products and services. A further list and description of these
risks, uncertainties, and other factors can be found in Lifeway's
Annual Report on Form 10-K for the fiscal year ended December
31, 2023 and Quarterly Report on Form 10-Q for the quarter ended
September 30, 2024. Copies of these
filings are available online
at https://www.sec.gov, http://lifewaykefir.com/investor-relations/,
or on request from Lifeway. Lifeway expressly disclaims any
obligation to update any forward-looking statements (including,
without limitation, to reflect changed assumptions, the occurrence
of anticipated or unanticipated events or new information), except
as required by law.
Media:
Derek Miller
Vice President of Communications, Lifeway Foods
Email: derekm@lifeway.net
General inquiries:
Lifeway Foods, Inc.
Phone: 847-967-1010
Email: info@lifeway.net
LIFEWAY FOODS, INC.
AND SUBSIDIARIES
|
Consolidated Balance
Sheets
|
September 30, 2024
and December 31, 2023
|
(In
thousands)
|
|
|
|
|
|
|
|
|
September 30,
2024
|
|
December
31,
|
|
|
(Unaudited)
|
|
2023
|
Current
assets
|
|
|
|
|
|
|
|
|
Cash and cash
equivalents
|
|
$
|
20,558
|
|
|
$
|
13,198
|
|
Accounts receivable,
net of allowance for credit losses and discounts & allowances
of $1,320 and $1,270 at September 30, 2024 and December 31, 2023
respectively
|
|
|
13,495
|
|
|
|
13,875
|
|
Inventories,
net
|
|
|
8,441
|
|
|
|
9,104
|
|
Prepaid expenses and
other current assets
|
|
|
1,893
|
|
|
|
2,019
|
|
Refundable income
taxes
|
|
|
379
|
|
|
|
–
|
|
Total current
assets
|
|
|
44,766
|
|
|
|
38,196
|
|
|
|
|
|
|
|
|
|
|
Property, plant and
equipment, net
|
|
|
26,310
|
|
|
|
22,764
|
|
Operating lease
right-of-use asset
|
|
|
136
|
|
|
|
192
|
|
Goodwill
|
|
|
11,704
|
|
|
|
11,704
|
|
Intangible assets,
net
|
|
|
6,493
|
|
|
|
6,898
|
|
Other
assets
|
|
|
1,900
|
|
|
|
1,900
|
|
Total
assets
|
|
$
|
91,309
|
|
|
$
|
81,654
|
|
|
|
|
|
|
|
|
|
|
Current
liabilities
|
|
|
|
|
|
|
|
|
Current portion of note
payable
|
|
$
|
–
|
|
|
$
|
1,250
|
|
Accounts
payable
|
|
|
11,117
|
|
|
|
9,976
|
|
Accrued
expenses
|
|
|
5,589
|
|
|
|
4,916
|
|
Accrued income
taxes
|
|
|
–
|
|
|
|
474
|
|
Total current
liabilities
|
|
|
16,706
|
|
|
|
16,616
|
|
Note
payable
|
|
|
–
|
|
|
|
1,483
|
|
Operating lease
liabilities
|
|
|
79
|
|
|
|
118
|
|
Deferred income
taxes, net
|
|
|
3,001
|
|
|
|
3,001
|
|
Total
liabilities
|
|
|
19,786
|
|
|
|
21,218
|
|
|
|
|
|
|
|
|
|
|
Commitments and
contingencies (Note 9)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders'
equity
|
|
|
|
|
|
|
|
|
Preferred stock, no par
value; 2,500 shares authorized; no shares issued or outstanding at
September 30, 2024 and December 31, 2023
|
|
|
–
|
|
|
|
–
|
|
Common stock, no par
value; 40,000 shares authorized; 17,274 shares issued; 14,816 and
14,691 outstanding at September 30, 2024 and December 31, 2023,
respectively
|
|
|
6,509
|
|
|
|
6,509
|
|
Paid-in
capital
|
|
|
5,915
|
|
|
|
4,825
|
|
Treasury stock, at
cost
|
|
|
(15,883)
|
|
|
|
(16,695)
|
|
Retained
earnings
|
|
|
74,982
|
|
|
|
65,797
|
|
Total stockholders'
equity
|
|
|
71,523
|
|
|
|
60,436
|
|
|
|
|
|
|
|
|
|
|
Total liabilities
and stockholders' equity
|
|
$
|
91,309
|
|
|
$
|
81,654
|
|
LIFEWAY FOODS, INC.
AND SUBSIDIARIES
|
Consolidated
Statements of Operations
|
For the three and
nine months ended September 30, 2024 and 2023
|
(Unaudited)
|
(In thousands,
except per share data)
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months
Ended
September
30,
|
|
Nine months
Ended
September
30,
|
|
|
2024
|
|
2023
|
|
2024
|
|
2023
|
|
|
|
|
|
|
|
|
|
Net
sales
|
|
$
|
46,095
|
|
|
$
|
40,896
|
|
|
$
|
139,886
|
|
|
$
|
118,030
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of goods
sold
|
|
|
33,508
|
|
|
|
29,099
|
|
|
|
101,127
|
|
|
|
85,428
|
|
Depreciation
expense
|
|
|
720
|
|
|
|
654
|
|
|
|
2,082
|
|
|
|
1,953
|
|
Total cost of goods
sold
|
|
|
34,228
|
|
|
|
29,753
|
|
|
|
103,209
|
|
|
|
87,381
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross
profit
|
|
|
11,867
|
|
|
|
11,143
|
|
|
|
36,677
|
|
|
|
30,649
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Selling
expense
|
|
|
3,979
|
|
|
|
2,884
|
|
|
|
11,256
|
|
|
|
8,974
|
|
General and
administrative expense
|
|
|
3,564
|
|
|
|
3,085
|
|
|
|
11,877
|
|
|
|
10,028
|
|
Amortization
expense
|
|
|
135
|
|
|
|
135
|
|
|
|
405
|
|
|
|
405
|
|
Total operating
expenses
|
|
|
7,678
|
|
|
|
6,104
|
|
|
|
23,538
|
|
|
|
19,407
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from
operations
|
|
|
4,189
|
|
|
|
5,039
|
|
|
|
13,139
|
|
|
|
11,242
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other income
(expense):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest
expense
|
|
|
(4)
|
|
|
|
(109)
|
|
|
|
(102)
|
|
|
|
(322)
|
|
Gain on sale of
property and equipment
|
|
|
3
|
|
|
|
–
|
|
|
|
3
|
|
|
|
33
|
|
Other income (expense),
net
|
|
|
138
|
|
|
|
(1)
|
|
|
|
153
|
|
|
|
(1)
|
|
Total other income
(expense)
|
|
|
137
|
|
|
|
(110)
|
|
|
|
54
|
|
|
|
(290)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income before
provision for income taxes
|
|
|
4,326
|
|
|
|
4,929
|
|
|
|
13,193
|
|
|
|
10,952
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Provision for income
taxes
|
|
|
1,350
|
|
|
|
1,517
|
|
|
|
4,008
|
|
|
|
3,554
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net
income
|
|
$
|
2,976
|
|
|
$
|
3,412
|
|
|
$
|
9,185
|
|
|
$
|
7,398
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net earnings per
common share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
0.20
|
|
|
$
|
0.23
|
|
|
$
|
0.62
|
|
|
$
|
0.50
|
|
Diluted
|
|
$
|
0.19
|
|
|
$
|
0.23
|
|
|
$
|
0.60
|
|
|
$
|
0.49
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average
common shares outstanding:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
14,801
|
|
|
|
14,677
|
|
|
|
14,740
|
|
|
|
14,659
|
|
Diluted
|
|
|
15,265
|
|
|
|
15,101
|
|
|
|
15,194
|
|
|
|
15,063
|
|
LIFEWAY FOODS, INC.
AND SUBSIDIARIES
|
Consolidated
Statements of Cash Flows
|
(Unaudited)
|
(In
thousands)
|
|
|
|
|
|
|
|
|
Nine months ended
September 30,
|
|
|
2024
|
|
2023
|
Cash flows from
operating activities:
|
|
|
|
|
|
|
|
|
Net
income
|
|
$
|
9,185
|
|
|
$
|
7,398
|
|
Adjustments to
reconcile net income to operating cash flow:
|
|
|
|
|
|
|
|
|
Depreciation and
amortization
|
|
|
2,487
|
|
|
|
2,358
|
|
Stock-based
compensation
|
|
|
1,898
|
|
|
|
1,078
|
|
Non-cash interest
expense
|
|
|
17
|
|
|
|
5
|
|
Bad debt
expense
|
|
|
–
|
|
|
|
2
|
|
Gain on sale of
equipment
|
|
|
(3)
|
|
|
|
(33)
|
|
(Increase)
decrease in operating assets:
|
|
|
|
|
|
|
|
|
Accounts
receivable
|
|
|
379
|
|
|
|
(1,683)
|
|
Inventories
|
|
|
663
|
|
|
|
310
|
|
Refundable income
taxes
|
|
|
(379)
|
|
|
|
(216)
|
|
Prepaid expenses and
other current assets
|
|
|
125
|
|
|
|
(176)
|
|
Increase
(decrease) in operating liabilities:
|
|
|
|
|
|
|
|
|
Accounts
payable
|
|
|
949
|
|
|
|
928
|
|
Accrued
expenses
|
|
|
694
|
|
|
|
1,673
|
|
Accrued income
taxes
|
|
|
(474)
|
|
|
|
500
|
|
Net cash provided by
operating activities
|
|
|
15,541
|
|
|
|
12,144
|
|
|
|
|
|
|
|
|
|
|
Cash flows from
investing activities:
|
|
|
|
|
|
|
|
|
Purchases of property
and equipment
|
|
|
(5,445)
|
|
|
|
(3,146)
|
|
Proceeds from sales or
equipment
|
|
|
14
|
|
|
|
40
|
|
Purchase of
investments
|
|
|
–
|
|
|
|
(100)
|
|
Net cash used in
investing activities
|
|
|
(5,431)
|
|
|
|
(3,206)
|
|
|
|
|
|
|
|
|
|
|
Cash flows from
financing activities:
|
|
|
|
|
|
|
|
|
Repayment of note
payable
|
|
|
(2,750)
|
|
|
|
(750)
|
|
Net cash used in
financing activities
|
|
|
(2,750)
|
|
|
|
(750)
|
|
|
|
|
|
|
|
|
|
|
Net increase in cash
and cash equivalents
|
|
|
7,360
|
|
|
|
8,188
|
|
|
|
|
|
|
|
|
|
|
Cash and cash
equivalents at the beginning of the period
|
|
|
13,198
|
|
|
|
4,444
|
|
|
|
|
|
|
|
|
|
|
Cash and cash
equivalents at the end of the period
|
|
$
|
20,558
|
|
|
$
|
12,632
|
|
|
|
|
|
|
|
|
|
|
Supplemental cash
flow information:
|
|
|
|
|
|
|
|
|
Cash paid for income
taxes, net of (refunds)
|
|
$
|
4,861
|
|
|
$
|
3,270
|
|
Cash paid for
interest
|
|
$
|
95
|
|
|
$
|
343
|
|
|
|
|
|
|
|
|
|
|
Non-cash investing
activities
|
|
|
|
|
|
|
|
|
Accrued purchase of
property and equipment
|
|
$
|
331
|
|
|
$
|
194
|
|
Increase in
right-of-use assets and operating lease obligations
|
|
$
|
–
|
|
|
$
|
86
|
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/lifeway-foods-announces-strong-results-for-the-third-quarter-and-nine-months-ended-september-30-2024-302305179.html
SOURCE Lifeway Foods, Inc.